| Followers | 24 |
| Posts | 1494 |
| Boards Moderated | 0 |
| Alias Born | 10/05/2015 |
Friday, July 07, 2017 2:43:44 PM
Started this board as have not seen a forum to discuss DBVT whether on Ihub or other well known platforms.
Is anybody out here?
Have held DBVT for over two years now, anyone else in the same or similar boats?
Is anybody out here?
Have held DBVT for over two years now, anyone else in the same or similar boats?
Recent DBVT News
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/01/2026 08:25:46 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/30/2026 09:30:48 PM
- DBV Technologies Reports First Quarter 2026 Financial Results • GlobeNewswire Inc. • 04/30/2026 08:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 04/30/2026 08:24:44 PM
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of March 31, 2026 • GlobeNewswire Inc. • 04/02/2026 08:30:00 PM
- DBV Technologies Announces Filing of 2025 Annual Report on Form 10-K and Universal Registration Document • GlobeNewswire Inc. • 03/26/2026 09:19:05 PM
- DBV Technologies Reports Full Year 2025 Financial Results and Business Update • GlobeNewswire Inc. • 03/26/2026 09:06:11 PM
- DBV Technologies to Join CAC Mid 60 and SBF 120 Indices Following Euronext Paris Annual Review • GlobeNewswire Inc. • 03/24/2026 08:30:00 PM
- DBV Technologies to Participate in Upcoming March Investor Conferences • GlobeNewswire Inc. • 03/04/2026 09:30:00 PM
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of February 28, 2026 • GlobeNewswire Inc. • 03/03/2026 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 12:54:26 PM
- DBV Technologies Highlights Additional Data from Successful Phase 3 VITESSE Study at the AAAAI 2026 Annual Meeting • GlobeNewswire Inc. • 02/28/2026 07:25:00 PM
- DBV Technologies to Present Additional Data from the VITESSE Phase 3 Study of the VIASKIN® Peanut Patch in Children Ages 4-7 Years and Discuss Future of EPIT in the Treatment Landscape at AAAAI 2026 Annual Meeting • GlobeNewswire Inc. • 02/10/2026 09:30:00 PM
- DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit • GlobeNewswire Inc. • 02/09/2026 09:30:00 PM
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of January 31, 2026 • GlobeNewswire Inc. • 02/05/2026 09:30:00 PM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/03/2026 07:00:02 PM
- DBV Technologies Announces €166.7 Million in Gross Proceeds Following the Full Exercise of the ABSA Warrants and BS Warrants Issued on its March 2025 Financing • GlobeNewswire Inc. • 01/16/2026 11:11:29 PM
- Information Regarding the Total number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 • GlobeNewswire Inc. • 01/12/2026 09:00:00 PM
- Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF • GlobeNewswire Inc. • 01/07/2026 09:00:00 PM
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of December 31, 2025 • GlobeNewswire Inc. • 01/05/2026 09:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/16/2025 09:21:29 PM
- DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years • GlobeNewswire Inc. • 12/16/2025 09:05:00 PM
- Information Regarding the Total Number of Voting Rights and Total Number of Shares of the Company as of November 30, 2025 • GlobeNewswire Inc. • 12/02/2025 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/25/2025 09:15:05 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/12/2025 09:59:58 PM
